More than half of a group of severely ill COVID-19 patients improved after receiving an experimental antiviral drug, although there is no way to know the odds of that happening without the drug, because there was no comparison group, doctors said on Friday.
The results published in the New England Journal of Medicine are the first in COVID-19 patients for remdesivir.
The Gilead Sciences drug has shown promise against other coronaviruses in the past and in lab tests against the one causing COVID-19, which has claimed more than 100,000 lives.
No drugs have been approved for treating the disease. At least five large studies are testing remdesivir, and the company also has given it to more than 1,700 patients on a case-by-case emergency basis.
Friday’s results are on 53 of those patients, ages 23 to 82, hospitalized in the US, Europe, Canada and Japan. Thirty-four of them were sick enough to require breathing machines.
All were given the drug intravenously for 10 days or as long as they tolerated it.
After 18 days on average, 36 patients, or 68 percent, needed less oxygen or breathing machine support.
Eight others worsened. Seven patients died, nearly all of them older than 70.
The 13 percent mortality rate is lower than seen in some other reports, but no true comparisons can be made without a study rigorously testing the drug in similar groups of patients, the authors said.
A dozen patients had serious problems, but it was not clear whether they were from the drug or their disease. Those included septic shock and trouble with kidneys and other organs. Four discontinued treatment because of health problems they developed.
“It looks encouraging,” said Elizabeth Hohmann, an infectious disease specialist at Massachusetts General Hospital who is helping lead one of the studies testing the drug.
The problems that occurred were not unexpected given the disease, she said.
Derek Angus, critical care chief at the University of Pittsburgh Medical Center who was not involved with the research, said the recovery rate is good, but “there is no way of knowing from this series if remdesivir was helpful.”
“We cannot draw definitive conclusions from these data, but the observations from this group of hospitalized patients who received remdesivir are hopeful,” said lead author Jonathan Grein, director of hospital epidemiology at Cedars-Sinai Medical Center in Los Angeles, in a statement from Gilead.
The Foster City, California-based company provided the medication and also helped analyze the results.
Results from more rigorous studies are expected by the end of this month.
Additional reporting by Bloomberg
CALL FOR PEACE: Czech President Petr Pavel raised concerns about China’s military maneuvers in the Taiwan Strait and its ‘unfriendly action’ in the South China Sea The leaders of three diplomatic allies — Guatemala, Paraguay and Palau — on Tuesday voiced support for Taiwan’s inclusion in the UN on the first day of the UN General Debate in New York. In his address during the 78th UN General Assembly, Palauan President Surangel Whipps Jr urged the UN and all parties involved in cross-strait issues to exercise restraint and seek a peaceful resolution. “The well-being and prosperity of nations and their economies are intrinsically linked to global peace and stability,” he said. He also thanked partner nations such as Taiwan, Australia, Japan and the US for providing assistance
CROSS-STRAIT CONCERNS: At the same US Congress hearing, Mira Resnick said a US government shutdown could affect weapons sales and licenses to allies such as Taiwan A Chinese blockade of Taiwan would be a “monster risk” for Beijing and likely to fail, while a military invasion would be extremely difficult, senior Pentagon officials told the US Congress on Tuesday. Growing worries of a conflict come as China has ramped up military pressure on Taiwan, holding large-scale war games simulating a blockade on the nation, while conducting near-daily warplane incursions and sending Chinese vessels around its waters. US Assistant Secretary of Defense for Indo-Pacific Security Affairs Ely Ratner said a blockade would be “a monster risk for the PRC [People’s Republic of China].” “It would likely not succeed, and it
AMPHIBIOUS EXERCISES: The defense ministry said that it had detected 24 Chinese PLA Air Force planes entering Taiwan’s air defense zone over the previous 24 hours Chinese movements around Taiwan were “abnormal,” Minister of National Defense Chiu Kuo-cheng (邱國正) said yesterday, flagging recent amphibious exercises in addition to drills Taipei has observed in China’s Fujian Province. Taiwan has reported a rise in Chinese military activity over the past week as dozens of fighters, drones, bombers and other aircraft, as well as warships, have operated around the nation. “Our initial analysis is that they are doing joint drills in September, including land, sea, air and amphibious,” Chiu told reporters at the legislature in Taipei. The “recent enemy situation is quite abnormal,” he said. The comments followed a statement from the
IN MOURNING: Tsai visited the site and spoke with family members of those killed, while all the major presidential candidates said they would temporarily halt campaigning A fire and subsequent explosions at a golf ball factory at Pingtung Technology Industrial Park (屏東科技產業園區) killed at least seven people, including four firefighters, and injured 98, while three were still missing, authorities said yesterday. The blaze at Launch Technologies Co’s (明揚國際) plant on Jingjian Road raged for more than 12 hours after it started at about 5pm on Friday, officials said. The Pingtung County Fire Bureau early yesterday used large excavators to search for missing people, while family members waited at the scene. Pingtung County Fire Bureau Director Hsu Mei-hsueh (許美雪) said the bureau received a call about the fire at 5:31pm